X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (158) 158
oncology (148) 148
index medicus (127) 127
female (107) 107
middle aged (94) 94
cancer (87) 87
aged (86) 86
chemotherapy (78) 78
locally advanced head (76) 76
radiotherapy (74) 74
adult (71) 71
male (69) 69
treatment outcome (56) 56
radiation-therapy (52) 52
squamous-cell carcinoma (51) 51
care and treatment (44) 44
neoplasm staging (44) 44
surgery (44) 44
prognosis (43) 43
antineoplastic combined chemotherapy protocols - therapeutic use (38) 38
cisplatin (37) 37
breast cancer (36) 36
hematology, oncology and palliative medicine (36) 36
radiology, nuclear medicine & medical imaging (36) 36
locally advanced (34) 34
medicine & public health (33) 33
squamous cell carcinoma (30) 30
survival analysis (30) 30
aged, 80 and over (29) 29
combined modality therapy (29) 29
carcinoma (28) 28
cisplatin - administration & dosage (28) 28
disease-free survival (28) 28
neoadjuvant chemotherapy (27) 27
antineoplastic agents - therapeutic use (25) 25
chemoradiotherapy (25) 25
head and neck cancer (25) 25
radiation therapy (25) 25
therapy (25) 25
tumors (25) 25
neoadjuvant therapy (24) 24
survival (24) 24
analysis (23) 23
basal cell carcinoma (22) 22
carcinoma, squamous cell - pathology (22) 22
research (22) 22
carcinoma, squamous cell - therapy (21) 21
health aspects (21) 21
metastasis (21) 21
radiation (21) 21
follow-up studies (20) 20
antineoplastic combined chemotherapy protocols - adverse effects (19) 19
cancer therapies (19) 19
cervical cancer (19) 19
locally advanced breast cancer (19) 19
prospective studies (19) 19
risk factors (19) 19
vismodegib (19) 19
carcinoma, squamous cell - mortality (18) 18
fluorouracil - administration & dosage (18) 18
head and neck neoplasms - radiotherapy (18) 18
locally advanced-carcinoma (18) 18
neck-cancer (18) 18
retrospective studies (18) 18
trial (18) 18
cancer patients (17) 17
carcinoma, squamous cell - radiotherapy (17) 17
patients (16) 16
skin neoplasms - pathology (16) 16
survival rate (16) 16
toxicity (16) 16
chemoradiation (15) 15
head and neck neoplasms - therapy (15) 15
induction chemotherapy (15) 15
oncology, experimental (15) 15
breast neoplasms - drug therapy (14) 14
cancer research (14) 14
carcinoma, squamous cell - drug therapy (14) 14
chemotherapy, adjuvant (14) 14
clinical trials (14) 14
head and neck neoplasms - pathology (14) 14
medical prognosis (14) 14
breast neoplasms - pathology (13) 13
dermatology (13) 13
expression (13) 13
locally advanced basal cell carcinoma (13) 13
medical research (13) 13
radiology (13) 13
uterine cervical neoplasms - pathology (13) 13
animals (12) 12
carboplatin (12) 12
head and neck neoplasms - drug therapy (12) 12
hedgehog pathway inhibitor (12) 12
locally advanced cervical cancer (12) 12
medicine, experimental (12) 12
neck (12) 12
open-label (12) 12
phase-ii (12) 12
phase-iii trial (12) 12
antineoplastic agents (11) 11
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of the American Academy of Dermatology, ISSN 0190-9622, 2016, Volume 75, Issue 1, pp. 113 - 125.e5
Background The hedgehog pathway inhibitor sonidegib demonstrated meaningful tumor shrinkage in more than 90% of patients with locally advanced basal cell... 
Dermatology | Basal Cell Carcinoma Outcomes with LDE225 Treatment study | hedgehog pathway inhibitor | sonidegib | locally advanced basal cell carcinoma | metastatic basal cell carcinoma | advanced basal cell carcinoma | Locally advanced basal cell carcinoma | Advanced basal cell carcinoma | Metastatic basal cell carcinoma | Sonidegib | Hedgehog pathway inhibitor | HEDGEHOG PATHWAY | MULTICENTER | VISMODEGIB | MANAGEMENT | EFFICACY | GUIDELINES | OPEN-LABEL | DERMATOLOGY | DOSE-ESCALATION | UPDATE | INHIBITOR | Skin Neoplasms - drug therapy | Humans | Middle Aged | Carcinoma, Basal Cell - secondary | Biphenyl Compounds - adverse effects | Male | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Biphenyl Compounds - therapeutic use | Young Adult | Pyridines - adverse effects | Antineoplastic Agents - adverse effects | Aged, 80 and over | Adult | Female | Smoothened Receptor - antagonists & inhibitors | Pyridines - therapeutic use | Skin Neoplasms - pathology | Pyridines - administration & dosage | Double-Blind Method | Survival Rate | Disease Progression | Biphenyl Compounds - administration & dosage | Carcinoma, Basal Cell - drug therapy | Aged | Medical research | Care and treatment | Basal cell carcinoma | Analysis | Patient outcomes | Corn | Medicine, Experimental | Skin | Metastasis | Drug therapy | Cancer
Journal Article
Journal Article
Future Oncology, ISSN 1479-6694, 02/2015, Volume 11, Issue 4, pp. 703 - 712
Basal cell carcinoma (BCC) is the most common skin cancer worldwide. Most occur on the head and neck, where cosmetic and functional outcomes are critical. BCC... 
basal cell carcinoma | vismodegib | locally advanced basal cell carcinoma | therapy | HEAD | MANAGEMENT | GUIDELINES | ACQUIRED-RESISTANCE | PERINEURAL SPREAD | MOHS MICROGRAPHIC SURGERY | NONMELANOMA SKIN-CANCER | ONCOLOGY | SURGICAL EXCISION | HEDGEHOG PATHWAY INHIBITOR | RECURRENCE
Journal Article
Journal Article
European Journal of Dermatology, ISSN 1167-1122, 11/2018, Volume 28, Issue 6, pp. 775 - 783
Journal Article
International Medical Case Reports Journal, ISSN 1179-142X, 2018, Volume 11, pp. 177 - 179
Journal Article
Journal of the American Academy of Dermatology, ISSN 0190-9622, 2015, Volume 72, Issue 6, pp. 1021 - 1026.e8
Journal Article
by Lin, Q and Li, Y and Zhang, D and Jin, HJ
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, ISSN 0394-6320, 12/2016, Volume 29, Issue 4, pp. 784 - 789
Decreasing levels of cytokines are associated with better responses to therapies, while increasing levels are related to progression or recurrence and... 
SURVIVAL | PROANGIOGENIC CYTOKINES | facial surgery | advanced basal cell carcinoma (aBCC) | ALPHA | locally advanced basal cell carcinoma | IMMUNOLOGY | PATHOLOGY | BIOMARKERS | PROINFLAMMATORY CYTOKINE EXPRESSION | THERAPY | pro-inflammatory serum cytokines | PHARMACOLOGY & PHARMACY | GROWTH-FACTOR | HUMAN HEAD
Journal Article
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.